These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
97 related items for PubMed ID: 10927617
1. Insulin activation of insulin receptor kinase in erythrocytes is not altered in non-insulin-dependent diabetes and not influenced by hyperglycemia. Klein HH, Müller R, Drenckhan M, Schütt M, Bätge B, Fehm HL. J Endocrinol; 2000 Aug; 166(2):275-81. PubMed ID: 10927617 [Abstract] [Full Text] [Related]
2. Elevation of serum insulin concentration during euglycemic hyperinsulinemic clamp studies leads to similar activation of insulin receptor kinase in skeletal muscle of subjects with and without NIDDM. Klein HH, Vestergaard H, Kotzke G, Pedersen O. Diabetes; 1995 Nov; 44(11):1310-7. PubMed ID: 7589829 [Abstract] [Full Text] [Related]
3. Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus. Gumbiner B, Polonsky KS, Beltz WF, Griver K, Wallace P, Brechtel G, Henry RR. J Clin Endocrinol Metab; 1990 Jun; 70(6):1594-602. PubMed ID: 2189885 [Abstract] [Full Text] [Related]
4. A microtiter well assay system to measure insulin activation of insulin receptor kinase in intact human mononuclear cells. Decreased insulin effect in cells from patients with NIDDM. Klein HH, Kowalewski B, Drenckhan M, Neugebauer S, Matthaei S, Kotzke G. Diabetes; 1993 Jun; 42(6):883-90. PubMed ID: 8388342 [Abstract] [Full Text] [Related]
5. Insulin-receptor tyrosine kinase activity is decreased in erythrocytes from non-obese patients with NIDDM. Santos RF, Palmieri MG, Wajchenberg BL, Azhar S. Horm Metab Res; 1994 Jun; 26(6):283-7. PubMed ID: 7927191 [Abstract] [Full Text] [Related]
6. Glucose and gluconeogenic substrate exchange by the forearm skeletal muscle in hyperglycemic and insulin-treated type II diabetic patients. Capaldo B, Napoli R, Di Bonito P, Albano G, Saccà L. J Clin Endocrinol Metab; 1990 Nov; 71(5):1220-3. PubMed ID: 2229281 [Abstract] [Full Text] [Related]
7. Delayed intracellular dissociation of the insulin-receptor complex impairs receptor recycling and insulin processing in cultured Epstein-Barr virus-transformed lymphocytes from insulin-resistant subjects. Sesti G, D'Alfonso R, Vargas Punti MD, Tullio AN, Liu YY, Federici M, Borboni P, Marini MA, Lauro R, Fusco A. Diabetologia; 1996 Mar; 39(3):289-95. PubMed ID: 8721774 [Abstract] [Full Text] [Related]
8. Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Perriello G, Pampanelli S, Del Sindaco P, Lalli C, Ciofetta M, Volpi E, Santeusanio F, Brunetti P, Bolli GB. Diabetes; 1997 Jun; 46(6):1010-6. PubMed ID: 9166673 [Abstract] [Full Text] [Related]
9. Insulin and high glucose modulation of phosphatase and reductase enzymes in the human erythrocytes: a comparative analysis in normal and diabetic states. Marques F, Crespo ME, Silva ZI, Bicho M. Diabetes Res Clin Pract; 2000 Mar; 47(3):191-8. PubMed ID: 10741568 [Abstract] [Full Text] [Related]
10. Regulation of rat insulin-receptor kinase by glucose in vivo. Bryer-Ash M. Diabetes; 1991 May; 40(5):633-40. PubMed ID: 1673663 [Abstract] [Full Text] [Related]
11. Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects. Miele C, Formisano P, Condorelli G, Caruso M, Oriente F, Andreozzi F, Tocchetti CG, Riccardi G, Beguinot F. Diabetologia; 1997 Apr; 40(4):421-9. PubMed ID: 9112019 [Abstract] [Full Text] [Related]
12. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus. Shapiro ET, Van Cauter E, Tillil H, Given BD, Hirsch L, Beebe C, Rubenstein AH, Polonsky KS. J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533 [Abstract] [Full Text] [Related]
13. Relative hyperproinsulinemia of NIDDM persists despite the reduction of hyperglycemia with insulin or sulfonylurea therapy. Rachman J, Levy JC, Barrow BA, Manley SE, Turner RC. Diabetes; 1997 Oct; 46(10):1557-62. PubMed ID: 9313749 [Abstract] [Full Text] [Related]
18. Metabolic abnormalities in offspring of NIDDM patients with a family history of diabetes mellitus. Migdalis IN, Zachariadis D, Kalogeropoulou K, Nounopoulos C, Bouloukos A, Samartzis M. Diabet Med; 1996 May; 13(5):434-40. PubMed ID: 8737025 [Abstract] [Full Text] [Related]
19. Short-term insulin therapy and normoglycemia. Effects on erythrocyte lipid peroxidation in NIDDM patients. Peuchant E, Delmas-Beauvieux MC, Couchouron A, Dubourg L, Thomas MJ, Perromat A, Clerc M, Gin H. Diabetes Care; 1997 Feb; 20(2):202-7. PubMed ID: 9118775 [Abstract] [Full Text] [Related]
20. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus. Clark HE, Matthews DR. Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981 [Abstract] [Full Text] [Related] Page: [Next] [New Search]